The portal has guidance, tools and resources to support the core skills for communicating for safety. It links to, and supports, work undertaken by Australian health service organisations in the areas of clinical communication and can be used as a resource for further learning.
Found 319 result(s)
This page sets out the terms and conditions of use for the CHBOI Toolkit
Data for each of the items in the Atlas are displayed as graphs and maps to show variation in rates by geographic location of patient residence.
List of expert advisory groups for the Third Australian Atlas of Healthcare Variation, published in 2018.
The Mental Health Advisory Group was established in 2015 to provide advice, expertise and support to the Commission’s Mental Health Program.
The Commission has developed a range of tools and resources to help health service organisations deliver comprehensive care in alignment with the Comprehensive Care Standard.
To support a shared understanding of the Comprehensive Care Standard, the Commission has developed a conceptual model describing the key organisational requirements for supporting the delivery of comprehensive care in health services.
The majority of antimicrobial use in Australia occurs in the community, that is in general practice, community health services, aged care homes and other non-hospital settings.
Reducing avoidable hospital readmissions supports better health outcomes, improves patient safety and leads to greater efficiency in the health system.
Based on advice, feedback and discussions with clinical experts and health services from across Australia, the Commission has compiled a list of FAQs and resources that may assist health services in the prevention and reduction of hospital-acquired complications (HACs).
Explore these resources and share your feedback.
Effective surveillance of antimicrobial resistance (AMR) in acute and community settings informs strategies for infection prevention and control and antimicrobial stewardship (AMS).
Development of the HACs list involved a literature review, environmental scan, clinician-driven reports, a proof-of-concept study and subsequent refinements.
APAS collects, analyses and reports on de-identified patient-level antimicrobial resistance (AMR) data from routine susceptibility testing results.
This page provides resources and a reference table of medication safety alerts, notices and guidance issued by the Australian states and territories and by international organisations using the APINCHS classification. There could be other more recent alerts, advice and guidance related to other medicines or practice areas which may be relevant to you or your organisation.
In Australia, the APINCHS acronym and classification provides a framework to assist clinicians to focus on a group of medicines known to be associated with high potential for medication-related harm. APINCHS does not encompass all high risk medicines, but it is a valuable tool to raise clinician awareness and to educate them about medication safety systems.
Categorisation of and policy relating to high risk medicines may vary between states, territories and health service organisations. This means that health service organisations should have systems and process in place for the safe use of high risk medicines.
Medicine shortages and discontinuations can potentially compromise patient safety. Guidance and resources are issued, which advise on:
- strategies on conserving medicines during medicine shortages and associated safety considerations
- strategies and safety considerations during periods of medicine discontinuations.